Sun Pharma Advanced Research Company Limited — Financials & Forensics
Sector: Healthcare · NSE: SPARC · BSE: 532872 · ISIN: INE232I01014
18 Aug 2026
Add SPARC to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹137 Cr | ₹239 Cr | ₹76 Cr | ₹72 Cr | ₹1,879 Cr |
| EBITDA | ₹-187 Cr | ₹-214 Cr | ₹-402 Cr | ₹-323 Cr | ₹1,599 Cr |
| EBITDA margin | -136.1% | -89.7% | -532.2% | -450.2% | 85.1% |
| Profit after tax | ₹-203 Cr | ₹-223 Cr | ₹-387 Cr | ₹-343 Cr | ₹1,553 Cr |
Deeper analysis
Recent filings by Sun Pharma Advanced Research Company Limited
-
Shareholders meeting
10 Aug 2026 · General Update
-
Monitoring Agency Report for the Quarter ended June 30, 2026
10 Aug 2026 · Regulatory Compliance
-
Outcome of the Board Meeting
10 Aug 2026 · Financial Results
Never miss a filing again
About Sun Pharma Advanced Research Company Limited on Indian Stock Alerts
Indian Stock Alerts tracks Sun Pharma Advanced Research Company Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.